Found 5 matching trials
Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome
PHASE2The objective of the study was to generate the data necessary to determine ...
Location
GSK Investigational Site
Prevention Study in Adult Patients Suffering From Migraine Headaches
PHASE2Purpose of the study is to evaluate dose response relationship, efficacy, s...
Location
GSK Investigational Site
Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine
PHASE1This double-blind study will evaluate the pharmacokinetics of a single dose...
Location
GSK Investigational Site
Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study
PHASE4Gabapentin enacarbil (GEn; GSK1838262; HORIZANT), at a dose of 600 mg/day, ...
Location
GSK Investigational Site
Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects
PHASE1This is a double-blind, placebo-and active-controlled 3-period crossover st...
Location
GSK Investigational Site